Abstract:The effectiveness of oral, mock-, and immersion vaccination was investigated against white spot syndrome virus (WSSV) in crayfish. The most exposed WSSV envelope proteins VP19 and VP28 were used in different compositions and with different modes of applications. In experiment 1 crayfish were fed recombinant protein coated food pellets for 25 days, in experiment 2 the purified proteins were directly injected to them followed by one booster dose on 5th day and in experiment 3 the crayfish were left immersed in vaccines for 7h. Experimental crayfish were challenged on 3rd and 21st days after last vaccination. The overall result showed that VP28 group has lowest cumulative mortality percentage accounting 39.6% at 3rd day and 39.83% at 21st day when injected and it was 43.2% and 49% when fed orally and 46.3% and 46.5% when immersed at 3rd and 21st days, respectively (p<0.05). In VP19 and VP28 (50:50) mixture, mock vaccination showed better performance (36.5%) over immersion (53%) and oral vaccination (53.2%) when challenged on 3rd day and mock vaccination (36.50%) followed by oral (51%) and immersion vaccination (56.5%) on 21st day as well. The VP19 recombinant mock vaccination group performed better (52.91% of 3rd day and 56.46% of 21st day) than oral (76% of 3rd day and 82% of 21st day) and immersion (83% of 3rd day and 86.3% of 21st day) vaccine groups. All the experimental groups except VP19 were significantly different (p<0.05) from the control groups. A positive cumulative effect was observed when VP28 was mixed with VP19 in equal proportion in all the experimental trials, which shows the effectiveness of VP19 as a vaccine component too. In the present trial on the basis of cumulative mortality percentage it is found that mock-vaccination group is more effective than the oral vaccination and immersion vaccination. It also suggests that specific memory exists in crayfish and the effects of VP28 are significant. The effect of VP19 along with VP28 has also shown significant effect against WSSV.

Expression of Envelope Protein VP28 of Penaeus monodon WSSV in E. coli and the Effect Against WSSV

Increased resistance to white spot syndrome virus in Procambarus clarkii by injection of envelope protein VP28 expressed using recombinant baculovirus

Expression of Envelope- Protein VP28 -Gene from White Spot Syndrome Virus (WSSV) in Escherichia Coli

Oral Vaccination with Envelope Protein VP28 Against White Spot Syndrome Virus in Procambarus Clarkii Using Bacillus Subtilis As Delivery Vehicles.

Identification and Localization of a Prawn White Spot Syndrome Virus Gene That Encodes an Envelope Protein.

Oral Vaccination Trials with Crayfish, Procambarus Clarkii, to Induce Resistance to the White Spot Syndrome Virus

Role of Chymotrypsin-Like Serine Proteinase in White Spot Syndrome Virus Infection in Fenneropenaeus Chinensis.

Dietary Chitosan Nanoparticles Protect Crayfish Procambarus Clarkii Against White Spot Syndrome Virus (wssv) Infection

Antigenic and Immunogenic Properties of Truncated VP28 Protein of White Spot Syndrome Virus in Procambarus Clarkii

Characterization and Diagnostic Use of a Monoclonal Antibody for VP28 Envelope Protein of White Spot Syndrome Virus

The Expression of VP28 Gene from Prawn White Spot Syndrome Virus in Silkworm, Bombyx Mori

Production of Recombinant Enveloped Structural Proteins from the Chinese WSSV Isolate

EFFECT OF WHITE SPOT SYNDROME VIRUS ENVELOPE PROTEIN Vp28 EXPRESSED IN SILKWORM (BOMBYX MORI) PUPAE ON DISEASE RESISTENCE IN PROCAMBARUS CLARKII

Crayfish Procambarus Clarkii Protected Against White Spot Syndrome Virus by Oral Administration of Viral Proteins Expressed in Silkworms

Immune responses of Fenneropenaeus chinensis against white spot syndrome virus after oral delivery of VP28 using Bacillus subtilis as vehicles.

Proteomic Analysis of Shrimp White Spot Syndrome Viral Proteins and Characterization of a Novel Envelope Protein VP466 *

Characterization of a novel envelope protein (VP281) of shrimp white spot syndrome virus by mass spectrometry.

Identification of white spot syndrome virus (WSSV) envelope proteins involved in shrimp infection.

The Efficacy of Recombinant Vaccines Against White Spot Syndrome Virus in Procambarus Clarkii.

CLONING, EXPRESSION, IMMUNOGENICITY OF EXTRACELLULAR PROTEINASE FROM VIBRIO HARVEYI

A Novel Envelope Protein Involved in White Spot Syndrome Virus Infection